| Four New Drugs Are Around the Corner. Here’s What You Need to Know. | Ben Fidler | 08/15/19 | National |
| Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step | Ben Fidler | 08/09/19 | National |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details | Ben Fidler | 05/11/18 | National |
| CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo | Ben Fidler | 03/19/18 | Boston |
| Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More | Alex Lash | 01/05/18 | National |
| First U.S. Gene Therapy, Approved for Vision Loss, to Cost $850,000 | Alex Lash | 01/03/18 | National |
| Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More | Alex Lash | 03/17/17 | National |
| Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More | Ben Fidler | 02/17/17 | National |
| This Week in Drug Pricing and Post-Election Healthcare Policy News | Ben Fidler | 12/02/16 | National |
| Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More | Ben Fidler | 12/02/16 | National |
| Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies | Alex Lash | 11/29/16 | National |
